Skip to content
AwardedSpainGoods

El objeto del contrato viene determinado por el suministro del principio activo denominado "TRASTUZUMABDERUXTECAN 100MG VIAL PERFUSION IV".

Published
Published 10 March 2025

Overview

Dicho objeto corresponde al código 33690000-3 (Medicamentos diversos), de la nomenclatura Vocabulario Común deContratos (CPV) de la Comisión Europea.

Key details

Country
Spain
Status
Awarded
Category
Goods
Procedure
Direct
Published
10 March 2025
Classification (CPV)
Various medicinal products

Award outcome

Awarded value
€817,703
Award date
2 February 2025
Winner
  • DAIICHI SANKYO ESPAÑA, S.A.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    10 March 2025

Contracting authority

  • Dirección del Servicio Canario de Salud

    Procuring entity

    Las Palmas de Gran Canaria, Spain

    ID_PLATAFORMA: 21050950148855

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: El objeto del contrato viene determinado por el suministro del principio activo denominado "TRASTUZUMABDERUXTECAN 100MG VIAL PERFUSION IV". — won by DAIICHI SANKYO ESPAÑA, S.A. — Skim